Skip to main content
Equibles

WINTON GROUP Ltd

Position in VIR — Vir Biotechnology, Inc.

CIK 1612063 LONDON, X0
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,564,073
-$1,732,158 QoQ
Shares Held
153,491
-58.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#71
of 237 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. VIR ranks #13 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 254,408 $28,839,690
2 FTRE
Fortrea Holdings Inc.
 389,155 $6,771,297
3 EXEL
Exelixis, Inc.
 99,834 $5,431,967
4 TECH
BIO-TECHNE Corp
 67,227 $4,749,587
5 HALO
Halozyme Therapeutics, Inc.
 60,348 $4,723,437
6 VKTX
Viking Therapeutics, Inc.
 90,546 $3,532,199
7 ALNY
Alnylam Pharmaceuticals, Inc.
 7,880 $2,372,116
8 TRVI
Trevi Therapeutics, Inc.
 106,852 $1,992,789

All Filings in VIR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,564,073 153,491
2026-03-31 $3,296,231 367,883
2025-12-31 $1,141,515 189,306
2025-09-30 $329,758 57,751
2025-03-31 $229,288 35,384
2024-12-31 $677,004 92,235
2024-09-30 $980,927 130,965
2024-06-30 $887,427 99,711
2024-03-31 $820,965 81,043
2023-09-30 $140,015 14,943
2023-06-30 $489,888 19,971
2023-03-31 $1,628,620 69,988
2022-12-31 $1,334,824 52,739
2022-09-30 $1,111,337 57,642
2022-06-30 $1,216,727 47,771
2022-03-31 $394,519 15,339
2021-12-31 $544,896 13,014
2021-09-30 $597,703 13,734
2021-06-30 $620,550 13,125
2021-03-31 $576,787 11,250
2020-12-31 $404,217 15,094
2020-09-30 $1,791,030 52,171